These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18032036)

  • 1. The discovery of GSK221149A: a potent and selective oxytocin antagonist.
    Liddle J; Allen MJ; Borthwick AD; Brooks DP; Davies DE; Edwards RM; Exall AM; Hamlett C; Irving WR; Mason AM; McCafferty GP; Nerozzi F; Peace S; Philp J; Pollard D; Pullen MA; Shabbir SS; Sollis SL; Westfall TD; Woollard PM; Wu C; Hickey DM
    Bioorg Med Chem Lett; 2008 Jan; 18(1):90-4. PubMed ID: 18032036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat.
    McCafferty GP; Pullen MA; Wu C; Edwards RM; Allen MJ; Woollard PM; Borthwick AD; Liddle J; Hickey DM; Brooks DP; Westfall TD
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R299-305. PubMed ID: 17395790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokinetics.
    Borthwick AD; Davies DE; Exall AM; Livermore DG; Sollis SL; Nerozzi F; Allen MJ; Perren M; Shabbir SS; Woollard PM; Wyatt PG
    J Med Chem; 2005 Nov; 48(22):6956-69. PubMed ID: 16250654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo activity of the potent oxytocin antagonist on uterine activity in the rat.
    Ahn TG; Han SJ; Cho YS; An TH; Pak SC; Flouret G
    In Vivo; 2004; 18(6):763-6. PubMed ID: 15646817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: Identification, stereochemistry and initial SAR.
    Wyatt PG; Allen MJ; Borthwick AD; Davies DE; Exall AM; Hatley RJ; Irving WR; Livermore DG; Miller ND; Nerozzi F; Sollis SL; Szardenings AK
    Bioorg Med Chem Lett; 2005 May; 15(10):2579-82. PubMed ID: 15863320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency.
    Borthwick AD; Davies DE; Exall AM; Hatley RJ; Hughes JA; Irving WR; Livermore DG; Sollis SL; Nerozzi F; Valko KL; Allen MJ; Perren M; Shabbir SS; Woollard PM; Price MA
    J Med Chem; 2006 Jul; 49(14):4159-70. PubMed ID: 16821776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor.
    Cirillo R; Gillio Tos E; Schwarz MK; Quattropani A; Scheer A; Missotten M; Dorbais J; Nichols A; Borrelli F; Giachetti C; Golzio L; Marinelli P; Thomas RJ; Chevillard C; Laurent F; Portet K; Barberis C; Chollet A
    J Pharmacol Exp Ther; 2003 Jul; 306(1):253-61. PubMed ID: 12660315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor.
    Williams PD; Anderson PS; Ball RG; Bock MG; Carroll L; Chiu SH; Clineschmidt BV; Culberson JC; Erb JM; Evans BE
    J Med Chem; 1994 Mar; 37(5):565-71. PubMed ID: 8126695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives.
    Wyatt PG; Allen MJ; Chilcott J; Gardner CJ; Livermore DG; Mordaunt JE; Nerozzi F; Patel M; Perren MJ; Weingarten GG; Shabbir S; Woollard PM; Zhou P
    Bioorg Med Chem Lett; 2002 May; 12(10):1405-11. PubMed ID: 11992787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of fetal hypothalamus induces uterine contractions in pregnant rats at term.
    Endoh H; Fujioka T; Endo H; Inazuka Y; Furukawa S; Nakamura S
    Biol Reprod; 2008 Oct; 79(4):633-7. PubMed ID: 18550792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists.
    Quattropani A; Dorbais J; Covini D; Pittet PA; Colovray V; Thomas RJ; Coxhead R; Halazy S; Scheer A; Missotten M; Ayala G; Bradshaw C; De Raemy-Schenk AM; Nichols A; Cirillo R; Tos EG; Giachetti C; Golzio L; Marinelli P; Church DJ; Barberis C; Chollet A; Schwarz MK
    J Med Chem; 2005 Dec; 48(24):7882-905. PubMed ID: 16302826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformation.
    Williams PD; Ball RG; Clineschmidt BV; Culberson JC; Erb JM; Freidinger RM; Pawluczyk JM; Perlow DS; Pettibone DJ; Veber DF
    Bioorg Med Chem; 1994 Sep; 2(9):971-85. PubMed ID: 7712132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridyl-2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potency.
    Borthwick AD; Liddle J; Davies DE; Exall AM; Hamlett C; Hickey DM; Mason AM; Smith IE; Nerozzi F; Peace S; Pollard D; Sollis SL; Allen MJ; Woollard PM; Pullen MA; Westfall TD; Stanislaus DJ
    J Med Chem; 2012 Jan; 55(2):783-96. PubMed ID: 22239250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
    Flouret G; Chaloin O; Slaninová J
    J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design of orally bioavailable 2, 5-diketopiperazine oxytocin antagonists: from concept to clinical candidate for premature labor.
    Borthwick AD; Liddle J
    Med Res Rev; 2011 Jul; 31(4):576-604. PubMed ID: 20027670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomolar-affinity, non-peptide oxytocin receptor antagonists.
    Evans BE; Lundell GF; Gilbert KF; Bock MG; Rittle KE; Carroll LA; Williams PD; Pawluczyk JM; Leighton JL; Young MB
    J Med Chem; 1993 Dec; 36(25):3993-4005. PubMed ID: 8258821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of oxytocin and its receptor in nociceptive modulation in the central nucleus of amygdala of rats.
    Han Y; Yu LC
    Neurosci Lett; 2009 Apr; 454(1):101-4. PubMed ID: 19429063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the development of oxytocin antagonists for use in preterm labor.
    Pettibone DJ; Guidotti M; Harrell CM; Jasper JR; Lis EV; O'Brien JA; Reiss DR; Woyden CJ; Bock MG; Evans BE
    Adv Exp Med Biol; 1995; 395():601-12. PubMed ID: 8714024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7.
    Fragiadaki M; Magafa V; Borovicková L; Slaninová J; Cordopatis P
    Eur J Med Chem; 2007 Jun; 42(6):799-806. PubMed ID: 17316912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.